Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting G Theron, J Peter, R van Zyl-Smit, H Mishra, E Streicher, S Murray, ... American journal of respiratory and critical care medicine 184 (1), 132-140, 2011 | 403 | 2011 |
Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD RN van Zyl Smit, M Pai, WW Yew, CC Leung, A Zumla, ED Bateman, ... European respiratory journal 35 (1), 27-33, 2010 | 373 | 2010 |
The immunology of tuberculosis: from bench to bedside K Dheda, SK Schwander, B Zhu, RN van Zyl‐Smit, Y Zhang Respirology 15 (3), 433-450, 2010 | 326 | 2010 |
Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review RN van Zyl-Smit, A Zwerling, K Dheda, M Pai PloS one 4 (12), e8517, 2009 | 260 | 2009 |
Respiratory syncytial virus prefusion F protein vaccine in older adults A Papi, MG Ison, JM Langley, DG Lee, I Leroux-Roels, F Martinon-Torres, ... New England Journal of Medicine 388 (7), 595-608, 2023 | 257 | 2023 |
Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial CFN Koegelenberg, F Noor, ED Bateman, RN van Zyl-Smit, A Bruning, ... Jama 312 (2), 155-161, 2014 | 251 | 2014 |
T-cell interferon-γ release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings K Dheda, R van Zyl Smit, M Badri, M Pai Current opinion in pulmonary medicine 15 (3), 188-200, 2009 | 247 | 2009 |
Within-subject variability and boosting of T-cell interferon-γ responses after tuberculin skin testing RN van Zyl-Smit, M Pai, K Peprah, R Meldau, J Kieck, J Juritz, M Badri, ... American journal of respiratory and critical care medicine 180 (1), 49-58, 2009 | 244 | 2009 |
Tobacco smoking and COVID-19 infection RN van Zyl-Smit, G Richards, FT Leone The Lancet Respiratory Medicine 8 (7), 664-665, 2020 | 241 | 2020 |
Electronic cigarettes. A position statement of the forum of international respiratory societies DE Schraufnagel, F Blasi, MB Drummond, DCL Lam, E Latif, MJ Rosen, ... American journal of respiratory and critical care medicine 190 (6), 611-618, 2014 | 230 | 2014 |
Novel tests for diagnosing tuberculous pleural effusion: what works and what does not? A Trajman, M Pai, K Dheda, R van Zyl Smit, AA Zwerling, R Joshi, ... European Respiratory Journal 31 (5), 1098-1106, 2008 | 221 | 2008 |
The asthma–COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases? ED Bateman, HK Reddel, RN van Zyl-Smit, A Agusti The Lancet Respiratory Medicine 3 (9), 719-728, 2015 | 214 | 2015 |
Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples K Dheda, V Davids, L Lenders, T Roberts, R Meldau, D Ling, L Brunet, ... PloS one 5 (3), e9848, 2010 | 192 | 2010 |
Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients JG Peter, G Theron, R van Zyl-Smit, A Haripersad, L Mottay, S Kraus, ... European respiratory journal 40 (5), 1211-1220, 2012 | 177 | 2012 |
E-cigarette vapour enhances pneumococcal adherence to airway epithelial cells L Miyashita, R Suri, E Dearing, I Mudway, RE Dove, DR Neill, ... European Respiratory Journal 51 (2), 2018 | 145 | 2018 |
Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden RN van Zyl-Smit, A Binder, R Meldau, H Mishra, PL Semple, G Theron, ... PloS one 6 (12), e28815, 2011 | 133 | 2011 |
Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled … HAM Kerstjens, J Maspero, KR Chapman, RN van Zyl-Smit, M Hosoe, ... The Lancet Respiratory Medicine 8 (10), 1000-1012, 2020 | 132 | 2020 |
Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections R Gounden, C Bamford, R van Zyl-Smit, K Cohen, G Maartens BMC infectious diseases 9, 1-6, 2009 | 128 | 2009 |
Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa K Shean, E Streicher, E Pieterson, G Symons, R van Zyl Smit, G Theron, ... PloS one 8 (5), e63057, 2013 | 124 | 2013 |
Anaerobic bacterial fermentation products increase tuberculosis risk in antiretroviral-drug-treated HIV patients LN Segal, JC Clemente, Y Li, C Ruan, J Cao, M Danckers, A Morris, ... Cell host & microbe 21 (4), 530-537. e4, 2017 | 120 | 2017 |